Abstract:Background and objectives: Systemic lupus erythematosus (SLE) is distinguished by dysregulated immune system activity, resulting in a spectrum of clinical manifestations, with lupus nephritis being particularly prominent. This study endeavors to discern novel targets as potential therapeutic markers for this condition. Methods: Weighted correlation network analysis (WGCNA) was used to construct the network and select the key hub genes in the co-expression module based on the gene expression dataset GSE81622. Subsequently, functional enrichment and pathway analysis were performed for SLE and lupus nephritis. In addition, also identify genes and differences in SLE with lupus nephritis and methylation site. Finally, qRT-PCR and western blot were used to verify the up-regulated expression levels of the selected key genes. Results: Within the co-expression modules constructed by WGCNA, the MElightcyan module exhibited the strongest positive correlation with lupus nephritis (0.4, P = 0.003), while showing a weaker correlation with the control group SLE (0.058) and a negative correlation with the control group (-0.41, P = 0.002). Additionally, the MEgreenyellow module displayed the highest positive correlation with SLE (0.25), but its P value was 0.06, which did not reach statistical significance(P > 0.05). Furthermore, it had a negative correlation with the control group was (-0.38, P = 0.004). The module associated with lupus nephritis was characterized by processes such as neutrophil activation (neutrophil_activation), neutrophil degranulation (neutrophil_degranulation), neutrophil activation involved in immune response (neutrophil_activation_involved_in_immune_response), neutrophils mediated immune (neutrophil_mediated_immunity) and white blood cells degranulation (leukocyte_degranulation) and so on the adjustment of the process. Secondly, in the analysis of SLE samples, the identification of differentially expressed genes revealed 125 genes, with 49 being up-regulated and 76 down-regulated. In the case of lupus nephritis samples, 156 differentially expressed genes were discerned, include in 70 up-regulated and 86 down-regulated genes. When examining differential methylation sites, we observed 12432 such sites in the SLE sample analysis, encompassing 2260 hypermethylation sites and 10172 hypomethylation sites. In the lupus nephritis samples analysis, 9613 differential methylation sites were identified, comprising 4542 hypermethylation sites and 5071 hypomethylation sites. Substantiating our findings, experimental validation of the up-regulated genes in lupus nephritis confirmed increased levels of gene expression and protein expression for CEACAM1 and SLC2A5. Conclusions: We have identified several genes, notably CEACAM1 and SLC2A5, as potential markers for lupus nephritis. Their elevated expression levels and reduced DNA methylation in lupus nephritis contribute to a more comprehensive understanding of the aberrant epigenetic regulation of expression in this condition. These findings hold significant implications for the diagnosis and therapeutic strategies of lupus nephritis.

Current status on genetic research of lupus nephritis

Long Non-Coding RNAs in Systemic Lupus Erythematosus: New Insights into Disease Pathogenesis and Diagnosis.

New Horizons In The Genetic Etiology Of Systemic Lupus Erythematosus And Lupus-Like Disease: Monogenic Lupus And Beyond

Recent insights into the genetic basis of systemic lupus erythematosus

[Recent Advance in Genetics of Systemic Lupus Erythematosus].

Pathogenic Gene Spectrum and Clinical Implication in Chinese Patients with Lupus Nephritis

The genetics of systemic lupus erythematosus and implications for targeted therapy

Genome-wide Association Study of SNP- and Gene-Based Approaches to Identify Susceptibility Candidates for Lupus Nephritis in the Han Chinese Population.

Brief Report: identification of MTMR3 as a novel susceptibility gene for lupus nephritis in northern Han Chinese by shared-gene analysis with IgA nephropathy.

Systemic lupus erythematosus genetics: insights into pathogenesis and implications for therapy

Recognition of differently expressed genes and DNA methylation markers in patients with Lupus nephritis

Identification of ST3AGL4, MFHAS1, CSNK2A2 and CD226 As Loci Associated with Systemic Lupus Erythematosus (SLE) and Evaluation of SLE Genetics in Drug Repositioning

Association of systemic lupus erythematosus susceptibility genes with IgA nephropathy in a Chinese cohort.

Identification of 38 Novel Loci for Systemic Lupus Erythematosus and Genetic Heterogeneity Between Ancestral Groups.

Genetic diagnosis of hereditary nephrotic syndrome

Genetics of SLE: mechanistic insights from monogenic disease and disease-associated variants

Clinical features and genetic analysis of a patient with lupus nephritis due to a new variant of DNASElL3 gene

The Epigenetics of Lupus Erythematosus

Long-term renal outcomes and related risk factors of familial systemic lupus erythematosus patients with lupus nephritis .

Research progress in functional magnetic resonance imaging assessment of lupus nephritis kidney injury

Association Analysis of the MHC in Lupus Nephritis.